Comparison of the 99th percentiles of three troponin I assays in a large reference population
Insights
Comparing sensitive troponin assays is crucial. This study found variations in 99th percentiles across assays, with some showing gender differences, highlighting the need for careful assay selection in clinical practice.
Area of Science:
- Clinical Chemistry
- Cardiovascular Diagnostics
- Biomarker Assays
Background:
- The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force recommends comparing sensitive troponin assays.
- A large, healthy reference population is essential for accurate assay evaluation.
Purpose of the Study:
- To compare three contemporary sensitive troponin I assays.
- To determine the 99th percentiles for these assays in a large healthy population.
- To investigate the influence of age and gender on troponin I levels.
Main Methods:
- Troponin I concentrations were measured using three sensitive assays in 2404 healthy individuals and a subgroup of 908.
- Quantile regression was employed to calculate the 99th percentiles, accounting for the entire population distribution.
- Statistical analysis explored age and gender dependencies for each assay.
Main Results:
- The 99th percentiles were 21 ng/L (ARCHITECT STAT), 31 ng/L (ADVIA Centaur), and 28 ng/L (Dimension Vista).
- Gender differences in troponin I levels were observed for the Dimension Vista assay and the ARCHITECT assay subgroup.
- No significant age dependency was found across the assays.
Conclusions:
- Quantile regression effectively estimates 99th percentiles and their relationship with demographic factors.
- Assay-specific gender differences exist, necessitating consideration in clinical interpretation.
- The findings support the IFCC recommendation for comparative assay evaluation.
Background:
The IFCC Task Force on Clinical Applications of Cardiac Biomarkers suggests comparing several contemporary sensitive troponin assays in the same, sufficiently large reference population.
Methods:
Three contemporary sensitive assays were used to measure troponin I concentration in samples from a uniquely large healthy population (2404 individuals) and in a sub-group with tighter inclusion criteria of 908 individuals. The 99th percentiles were calculated using quantile regression which takes the entire population into account.
Results:
The 99th percentile for the ARCHITECT STAT Troponin I assay was 21 ng/L, 31 ng/L for the ADVIA Centaur Troponin I-Ultra assay and 28 ng/L for the Dimension Vista cTnI assay. Significantly higher values were found in males than in women only in the Dimension Vista cTnI assay and in the subgroup for the ARCHITECT STAT Troponin I assay.
Conclusions:
Quantile regression provides a tool to accurately estimate the 99th percentile and establish a continuous function of the relation between the 99th percentile and the age and gender. There was no age dependency demonstrated. A gender difference was found in one assay but inconclusive in another and not demonstrated in a third.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
10:01Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
